  MERCK CANINE DISTEMPER-ADENOVIRUS TYPE 2-PARAINFLUENZA-PARVOVIRUS VACCINE Modified Live Virus INDICATIONS: This product has been shown to be effective for vaccination of healthy dogs 6 weeks of age or older against canine distemper virus, canine adenovirus type 1 (hepatitis), canine parainfluenza virus and canine parvovirus. Duration of Immunity has not been established. To review efficacy and safety data, go to productdata.aphis.usda.gov. Data indicate the development of corneal opacity is not associated with the use of this product. DOSAGE AND ADMINISTRATION: Transfer contents of the sterile diluent vial to the Nobivac EDGE™ DAPPv vial aseptically. Mix gently until dissolved. Inject one dose (0.5 mL) subcutaneously. The initial dose may be given at 6 weeks of age or older. Repeat dose 2 to 4 weeks later. Two doses are required for primary immunization. The presence of maternal antibodies is known to interfere with the development of active immunity in dogs and additional boosters will be required in most young animals. Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. For more information on revaccination frequency, in general or in the face of maternal antibody, consult your veterinarian or the manufacturer. |
|
 25 x 0.5mL - Nobivac Edge DAPPv Canine Vaccine, Modified Live Virus |
|
Please contact us for discount pricing on large orders. Call toll free 1-800-892-6978 or email us at info@animalhealthusa.com | |||||||||||
